TOSOVRA

Serial Number 76137665
606

Registration Progress

Application Filed
Sep 28, 2000
Under Examination
Nov 6, 2001
Approved for Publication
Jul 25, 2001
Published for Opposition
Aug 14, 2001
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: TOSOVRA
Previous Owner: Parke, Davis & Company
Classes: 005

Trademark Image

TOSOVRA

Basic Information

Serial Number
76137665
Filing Date
September 28, 2000
Published for Opposition
August 14, 2001
Abandonment Date
May 7, 2003
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 7, 2003
Classes
005

Rights Holder

Parke, Davis & Company

03
Address
201 Tabor Road
Morris Plains, NJ 07950

Ownership History

Parke, Davis & Company

Original Applicant
03
Morris Plains, NJ

Parke, Davis & Company

Owner at Publication
03
Morris Plains, NJ

Legal Representation

Attorney
Belinda I. Berman

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

13 events
Date Code Type Description Documents
Jan 13, 2004 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 23, 2003 MAIL I PAPER RECEIVED Loading...
May 5, 2003 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 26, 2002 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 1, 2002 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 1, 2002 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 13, 2002 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 25, 2002 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 6, 2001 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 14, 2001 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 25, 2001 NPUB O NOTICE OF PUBLICATION Loading...
Mar 7, 2001 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 7, 2001 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of pain, epilepsy, mood disorders, anxiety, oncology, cardiovascular conditions, diabetic disease, auto-immune deficiency and anti-virals
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005